Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01177618 · ClinicalTrials.gov registry record

Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study

A clinical trial of Chronic Obstructive Pulmonary Disease, sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT01177618: Recruiting study of Chronic Obstructive Pulmonary Disease, sponsored by Brigham and Women's Hospital.

NCT01177618 is a study of Chronic Obstructive Pulmonary Disease that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 2,000 participants, above the 1,731-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (16% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01177618, a study of Chronic Obstructive Pulmonary Disease, is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

Chronic obstructive pulmonary disease (COPD) is often caused by cigarette smoking, but genetic predisposition also influences COPD susceptibility. The purpose of this study is to identify genetic factors that predispose some individuals to develop COPD.

Primary Outcome

Since this is an observational study, there are no primary outcomes

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 1994-07
Est. Completion 2027-07
Brigham and Women's Hospital

937 total trials

What NCT01177618 shows while recruiting

NCT01177618 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,731-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (16% higher).

The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 0 interventions.

NCT01177618 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01177618 about?

NCT01177618 is a clinical study titled "Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study". Chronic obstructive pulmonary disease (COPD) is often caused by cigarette smoking, but genetic predisposition also influences COPD susceptibility. The purpose of this study is to identify genetic factors that predispose some individuals to develop COPD.

What is the current status of trial NCT01177618?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 1994-07. Estimated completion is 2027-07.

What conditions does trial NCT01177618 study?

This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.

Who is sponsoring clinical trial NCT01177618?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01177618 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Obstructive Pulmonary Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01177618's enrollment target sits among peer trials

2,000 8th of 86 higher than 78 of 86 other Chronic Obstructive Pulmonary Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Obstructive Pulmonary Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01177618, the US trial registry maintained by the National Library of Medicine. NCT01177618 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.